Nexel Co Ltdspun Off From Korea University In 2012 With Its Proprietary Stem Cell Technology And By The End Of 2017 Has Introducedhepatosight S And Cardiosight S To The Markethttps Www Nexel Co Kr Private Office These Fully Functional Human Cell Products Can Currently Be Used For A Variety Of Researchincluding Drug Screening And Toxicity Testsduring Our Research With The Stem Cellwe Were Lucky Enough To Stumble Upon A Molecule With A Significant Anti Fibrotic Effectnexel Has Carried Out Various Studies To Optimize Its Stabilitymanufacturabilityand Efficacy By Modifying Its Structure In Collaboration With Respected Cros In South Koreathe New Drug Candidate Was Named Np 011Https Www Nexel Co Kr Open Spaceand Has 4 Folds Higher Anti Fibrotic Effect Compared To Its Parent Moleculethe Primary Indication For Np 011 Is Nash And Liver Fibrosisand Use In Other Fibrotic Diseases Are Currently Being Evaluatednexel S Goal For Np 011 Is To Find A Partner With Experience And Expertise For Co Development And File For Ind By The End Of 2019 With K Fdaif You Have Any Questions Regarding Either Of Nexel S Human Cells Or Protein Therapyplease Feel Free To Contact At Support Nexel Co Kr Thank You
